Expanding the Pathogen Panel in Wastewater Epidemiology to Influenza and Norovirus.
Rudolf MarktFabian StillebacherFabiana NägeleAnna KammererNico PeerMaria PayrChristoph ScheffknechtSilvina DriaSimon Draxl-WeiskopfMarkus MayrWolfgang RauchKreuzinger NLukas RainerFlorian BachnerMartin ZubaHerwig OstermannNina LacknerHeribert InsamAndreas Otto WagnerPublished in: Viruses (2023)
Since the start of the 2019 pandemic, wastewater-based epidemiology (WBE) has proven to be a valuable tool for monitoring the prevalence of SARS-CoV-2. With methods and infrastructure being settled, it is time to expand the potential of this tool to a wider range of pathogens. We used over 500 archived RNA extracts from a WBE program for SARS-CoV-2 surveillance to monitor wastewater from 11 treatment plants for the presence of influenza and norovirus twice a week during the winter season of 2021/2022. Extracts were analyzed via digital PCR for influenza A, influenza B, norovirus GI, and norovirus GII. Resulting viral loads were normalized on the basis of NH 4 -N. Our results show a good applicability of ammonia-normalization to compare different wastewater treatment plants. Extracts originally prepared for SARS-CoV-2 surveillance contained sufficient genomic material to monitor influenza A, norovirus GI, and GII. Viral loads of influenza A and norovirus GII in wastewater correlated with numbers from infected inpatients. Further, SARS-CoV-2 related non-pharmaceutical interventions affected subsequent changes in viral loads of both pathogens. In conclusion, the expansion of existing WBE surveillance programs to include additional pathogens besides SARS-CoV-2 offers a valuable and cost-efficient possibility to gain public health information.
Keyphrases
- sars cov
- wastewater treatment
- respiratory syndrome coronavirus
- public health
- health information
- antibiotic resistance genes
- anaerobic digestion
- risk factors
- gram negative
- healthcare
- antimicrobial resistance
- social media
- randomized controlled trial
- emergency department
- mental health
- multidrug resistant
- coronavirus disease
- study protocol
- drug induced
- ionic liquid
- candida albicans
- combination therapy
- electronic health record
- adverse drug